Home >> Tag Archives: Royal Philips—

Tag Archives: Royal Philips—

Philips WSI systems in Austria labs, 11/17

November 2017—Royal Philips announced that two pathology laboratories in Austria have made the transition to a fully digital workflow. The Pathology Institute in Hall and the Pathology Institute at Tirol Kliniken Innsbruck have fully digitized their diagnostic process with Philips IntelliSite Pathology Solution, a whole slide imaging system for primary diagnosis.

Read More »

Philips WSI system in two Austria labs

Sept. 11, 2017—Royal Philips announced that two pathology laboratories in Austria have made the transition to a fully digital workflow. The Pathology Institute in Hall and the Pathology Institute at Tirol Kliniken Innsbruck have fully digitized their diagnostic process with Philips IntelliSite Pathology Solution, a whole slide imaging system for primary diagnosis. Other laboratories that have digitized their workflow are ...

Read More »

Philips WSI system FDA OK’d for digital pathology

April 13, 2017—The FDA on April 12 permitted marketing of Royal Philips IntelliSite Pathology Solution (PIPS), the first whole slide imaging system that allows for review and interpretation of digital surgical pathology slides prepared from biopsied tissue. This is the first time the FDA has permitted the marketing of a WSI system for these purposes. “The system enables pathologists to read ...

Read More »

Philips, Illumina to offer genomics solutions

Jan. 16, 2017—Royal Philips and Illumina announced a strategic collaboration that aims to integrate Illumina’s sequencing systems for large-scale analysis of genetic variation and function and Philips’ IntelliSpace Genomics clinical informatics platform and to coordinate marketing and sales of the resulting solutions. Philips and Illumina will also seek to engage in clinical research collaborations with health systems in the U.S. ...

Read More »

Mass General will study Philips’ WSI for primary Dx

April 5, 2016—Royal Philips announced that Massachusetts General Hospital, Boston, will serve as a key testing site for a multicenter instrument precision study involving Philips’ digital pathology whole slide imaging IntelliSite Solution. The study is designed to show the reproducibility of the IntelliSite pathology solution in disease detection as part of the industry’s efforts to obtain regulatory clearance of WSI ...

Read More »

CE marking for digital pathology solution, 12/14

December 2014—Royal Philips announced it has acquired the CE mark for the diagnostic use of its Philips Digital Pathology Solution. European pathologists will now be able to use the full digital solution as an aid in diagnosis for routine pathology, including hematoxylin and eosin, immunohistochemistry, and special stained tissue sections.

Read More »
X